ESMO 2022 Conference Coverage


 

ESMO 2022 on the CheckMate 9LA Study Results: Clinical Outcomes in Patients With Tumor PD-L1<1% With 1L Nivo + Ipi + 2 Cycles of Chemo vs. Chemo Alone for mNSCLC

260 views
October 18, 2022
Comments 0
Login to view comments. Click here to Login